Sending Office: Honorable Tulsi Gabbard
The Opioid Crisis Accountability Act
Organizations endorsing the legislation: Public Citizen, CREDO, American Medical Student Association (AMSA), National Collaborative for Health Equity and Prescription Justice.
Current Cosponsors: Khanna*, Japayal
I hope you’ll consider joining us in introducing the Opioid Crisis Accountability Act of 2018.
For too long, major pharmaceutical companies have lied to the FDA, doctors, and the American people about the addictive nature of opioid drugs, just so they could sell more drugs and rake in the profits. At least 63,000 Americans died from opioid overdoses
in 2016 alone, with some projections suggesting that nearly 500,000 more deaths will occur in the next decade. Yet, none of these companies has been held fully accountable.
The Opioid Crisis Accountability Act of 2018 holds drug companies accountable for profiting from the opioid epidemic by:
- Prohibiting illegal marketing and distribution of opioids;
- Creating criminal liability for top company executives;
- Penalizing drug manufacturers who illegally advertise, market or distribute an opioid product; and
- Requiring drug makers to reimburse the country for the negative economic impact of their products.
Joining the efforts of Senators Bernie Sanders, Kamala Harris, Kirsten Gillibrand and Richard Blumenthal this bill bans any form of direct-to-consumer marketing of opioids that falsely suggest that the product has no addiction-forming or addiction-sustaining
qualities or risks. Companies found in violation would be fined 25 percent of the profits from their opioid products. Drug manufacturers who illegally advertise, market or distribute an opioid product would also be stripped of any remaining period of market
exclusivity for that opioid product, and would lose half of the remaining exclusivity period on other opioid products they have on the market.
The legislation would also fine any company found liable for contributing to the opioid epidemic $7.8 billion – 10 percent of the annual cost of the opioid crisis. Additionally, the bill prevents companies from supplying a state or community with an unreasonable
number of opioids.
Please join me in becoming an original cosponsor of the The Opioid Crisis Accountability Act of 2018. We plan to introduce the bill soon, so If you would like to be added as a cosponsor or have any additional questions please contact Adam Schantz, email@example.com.
e-Dear Colleague version 2.0